[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Dobbs et al., 1988 - Google Patents

Human T-cell activation: comparative studies on the role of different phorbol esters.

Dobbs et al., 1988

View PDF
Document ID
376811115398746234
Author
Dobbs J
Katz D
Publication year
Publication venue
Immunology

External Links

Snippet

We confirm here previous studies that have shown synergy between anti-CD3 and phorbol esters in the induction of T-cell proliferation. However, for this study we have used tonsillar rather than peripheral blood T cells, and have compared the role of different phorbol esters …
Continue reading at www.ncbi.nlm.nih.gov (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells

Similar Documents

Publication Publication Date Title
Marten et al. Enhanced lytic activity of cytokine-induced killer cells against multiple myeloma cells after co-culture with idiotype-pulsed dendritic cells
Chouaib et al. Interleukin 12 induces the differentiation of major histocompatibility complex class I-primed cytotoxic T-lymphocyte precursors into allospecific cytotoxic effectors.
Wagner et al. TT-cell interactions during the vitro cytotoxic allograft responses. I. Soluble products from activated Lyl+ T cells trigger autonomously antigen-primed Ly23+ T cells to cell proliferation and cytolytic activity.
Trivedi et al. Analysis of neonatal T cell and antigen presenting cell functions
Defrance et al. B cell growth-promoting activity of recombinant human interleukin 4.
Miller et al. Role of monocytes in the expansion of human activated natural killer cells
EP0112632B1 (en) Use of 8-substituted guanine derivatives in the manufacture of a medicament.
Lotze et al. In vitro growth of cytotoxic human lymphocytes. II. Use of T cell growth factor (TCGF) to clone human T cells.
JP2973322B2 (en) Immunomodulator
Schilbach et al. Human γδ T Lymphocytes Exert Natural and IL-2–Induced Cytotoxicity to Neuroblastoma Cells
Ransom et al. Interferon-gamma is produced by activated immature mouse thymocytes and inhibits the interleukin 4-induced proliferation of immature thymocytes.
Howe et al. Role of interleukin 1 in early T cell development: Lyt-2-L3T4-thymocytes bind and respond in vitro to recombinant IL 1.
Valerie et al. Immunomodulatory effects of interleukin-12 on human tumor-infiltrating lymphocytes
Märten et al. Generation of activated and antigen-specific T cells with cytotoxic activity after co-culture with dendritic cells
Dobbs et al. Human T-cell activation: comparative studies on the role of different phorbol esters.
Ko et al. CD73+ dendritic cells in cascading Th17 responses of experimental autoimmune uveitis-induced mice
Baxevanis et al. Increased generation of autologous tumor-reactive lymphocytes by anti-CD3 monoclonal antibody and prothymosin α
Evans et al. Amplification of immune T lymphocyte function in situ: the identification of active components of the immunologic network during tumor rejection.
Grimm et al. Characterization of interleukin-2-initiated versus OKT3-initiated human tumor-infiltrating lymphocytes from glioblastoma multiforme: growth characteristics, cytolytic activity, and cell phenotype
Ballas et al. Generation of cytotoxic T lymphocytes against modified self in the absence of antigen by interleukin 2-containing preparations
Krishnan et al. In vitro and in vivo immunosuppressive effects of supernatants from human choriocarcinoma cell lines
Yang et al. Differential in vitro activation of CD8-CD4+ and CD4-CD8+ T lymphocytes by combinations of anti-CD2 and anti-CD3 antibodies.
Salvadori et al. Activation by mitogens and superantigens of axolotl lymphocytes: functional characterization and ontogenic study
Pryjma et al. Monocyte-T-cell interactions in pokeweed mitogen-activated cultures.
Koyama et al. Differential activation of lymphokine‐activated killer cells with different surface phenotypes by cultivation with recombinant interleukin 2 or T‐cell growth factor in gastric cancer patients